Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytokinetics Inc (NASDAQ:CYTK)

6.91
Delayed Data
As of Feb 05
 -0.33 / -4.56%
Today’s Change
5.50
Today|||52-Week Range
13.18
-33.94%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Cytokinetics Inc have a median target of 19.00, with a high estimate of 24.00 and a low estimate of 15.00. The median estimate represents a +174.96% increase from the last price of 6.91.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Cytokinetics Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.23
Sales
$10.5M
Reporting Date
Feb 17

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 0.73%
 
 
 
 
 
 
Growthannually -150.41%
 
 
 
 
 
 

Sales

Growthquarterly 32.07%
 
 
 
 
 
 
Growthannually -35.22%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.